ArticleThe journal of allergy and clinical immunology. In practice2020
Oral challenge with trimethoprim-sulfamethoxazole in patients with "sulfa" antibiotic allergy.
Open access · greenAbstract read
In one paragraph
Article in The journal of allergy and clinical immunology. In practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 59 citations in OpenAlex.
- Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Inpatient direct oral challenge for sulfa antibiotic allergy: improving care in immunocompromised hosts.Infection control and hospital epidemiology · 2026Article
- Comparison between the Outcomes of Pentamidine and Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Non-HIV Patients: A Nationwide Japanese Retrospective Cohort Study.Internal medicine (Tokyo, Japan) · 2025Article
- International Validation of the SULF-FAST Risk-Stratification Tool for Sulfonamide Antibiotic Allergy.JAMA network open · 2025Article
- Article
- Point prevalence survey of antibiotic allergies in hospitalized patients.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions.Transplant infectious disease : an official journal of the Transplantation Society · 2024Review
- Therapeutic Myths in Solid Organ Transplantation Infectious Diseases.Open forum infectious diseases · 2024Article
- How to Define and Manage Low-Risk Drug Allergy Labels.The journal of allergy and clinical immunology. In practice · 2024Review
- Antibiotic prophylaxis in immunosuppressed patients - Missed opportunities from trimethoprim-sulfamethoxazole allergy label.The World Allergy Organization journal · 2024Review
- Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases.Clinical and experimental medicine · 2023Article
- Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule.JAMA network open · 2023Article
- Perioperative anaphylactic reactions to central venous and pulmonary artery catheters containing chlorhexidine, sulfadiazine, or latex: a historical cohort study.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023Article
- Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center.Transplant infectious disease : an official journal of the Transplantation Society · 2022Article
- Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks.The journal of allergy and clinical immunology. In practice · 2022Article
- Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.The World Allergy Organization journal · 2022Review
- Sulfonamide Hypersensitivity.Clinical reviews in allergy & immunology · 2022Review
- Reply to ''The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy".The journal of allergy and clinical immunology. In practice · 2021Article
- Non-IgE-Mediated Drug Hypersensitivity Reactions.Current allergy and asthma reports · 2021Review
- Outcome of trimethoprim-sulfamethoxazole challenge in previously reported patients with sulfa antibiotic allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Matthew S KrantzDepartments of Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn.
Cosby A StoneDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.
Andrew AbreoDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.
Elizabeth J PhillipsDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tenn; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia. Electronic address: elizabeth.j.phillips@vanderbilt.edu.
Vanderbilt University · USVanderbilt University Medical Center · US
Funding
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2015 to 2019
$13.0MCLINICAL PHARMACOLOGY TRAINING PROGRAMT32GM007569 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bjorn C Knollmann · 1985 to 2026
$12.4MSingle Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysisR21AI139021 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2018 to 2019
$435kNATIENS: A Phase III Randomized Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisR34AI136815 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2018 to 2018
$205kNIAID NIH HHS R21 AI139021NIAID NIH HHS R34 AI136815NIGMS NIH HHS P50 GM115305NIGMS NIH HHS T32 GM007569
Abstract
PubMed holds no abstract for this paper.
Indexed as
Drug HypersensitivityTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsDrug CombinationsHumansSulfonamidesAnti-Bacterial AgentsDrug CombinationsSulfonamidesTrimethoprim, Sulfamethoxazole Drug Combination
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.